Telix Pharmaceuticals | TLX - Assets



Telix Pharmaceuticals reported AUD1.52B in Assets for its fiscal semester ending in December of 2024.


Assets Change Date
Cochlear AUD 2.79B 41M Dec/2024
CSL USD 38.45B 425M Dec/2024
Integral Diagnostics AUD 744.28M 1.52M Jun/2024
Mayne Pharma AUD 1.14B 9.47M Jun/2024
Medical Developments International AUD 65.33M 6.17M Dec/2024
Mesoblast 669.15M 1.13M Jun/2024
Neuren Pharmaceuticals AUD 409.71M 181.55M Dec/2024
Pacific Edge NZD 37.03M 13.82M Mar/2025
Paradigm Biopharmaceuticals AUD 35.36M 7.97M Dec/2024
Polynovo AUD 108.72M 11.51M Jun/2024
PYC Therapeutics AUD 68.23M 23.01M Dec/2024
Ramsay Health Care AUD 20.66B 237M Dec/2024
ResMed USD 8.17B 1.03B Jun/2025
Sonic Healthcare AUD 15.38B 550.57M Dec/2024